After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, HALO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Halozyme Therapeutics Inc is $7.10B. A total of 0.84 million shares were traded on the day, compared to an average of 1.69M shares.
In the most recent transaction, Henderson Jeffrey William sold 10,000 shares of HALO for 50.01 per share on Jan 06 ’25. After the transaction, the Director now owns 43,611 company shares. In a previous transaction on Jan 06 ’25, JEFFREY HENDERSON bought 10,000 shares at 47.74 per share.
Among the insiders who sold shares, LaBarre Michael J. disposed of 10,000 shares on Oct 15 ’24 at a per-share price of $53.75. This resulted in the SVP, CHIEF TECHNICAL OFFICER holding 173,756 shares of HALO after the transaction. In another insider transaction, LaBarre Michael J. sold 10,000 shares at $53.26 per share on Oct 16 ’24. Company shares held by the SVP, CHIEF TECHNICAL OFFICER now total 173,756.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, HALO has a high of $65.53 and a low of $33.15.
As of this writing, HALO has an earnings estimate of $1.16 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.23 per share and a lower estimate of $1.11.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $3.56, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 4.00.
